- Sartorius Stedim ( Single-Use Modules Expedite Total Solutions )
- CARsgen Therapeutics Receives IND Clearance for BCMA-CAR-T Cells
- Dormant Neural Stem Cells in fruit flies activate to generate new brain cells
- Holmusk signs MoU with Janssen R&D to develop ‘digital mental health strategy’ in China
- Cognizant to acquire Zenith Technologies
- Ferring Pharma collaborates with WOOM
- Stoke Therapeutics announces pricing of IPO
- Be The Match BioTherapies partners with TrakCel
- LabCorp, Mt. Sinai Health System collaborate for establishment of AI-enabled Pathology Center of Excellence
- Sartorious starts up operations at expanded site in Puerto Rico
- 23Mofang proves PSR association with heredity in Chinese population
- Singapore behind China, Saudi Arabia in use of AI to improve diagnostic accuracy
- White Paper: Advanced Compliance For Use in Regulated Sectors
- Taiwan Expo in Penang for the first time
-
Singapore | 27 May 2019 | News
A Nutrition Pathway to Stamp out the Start of Cancer
In a landmark study, scientists at the Agency of Science, Technology and Research’s (A*STAR) Genome Inst...Read more
Japan | 24 May 2019 | News
Scientists develop technique for better detection of breast cancer
Researchers at Okayama University report in the journal Sensors and Actuators B: Chemical that terah...Read more
-
China | 20 June 2019 | News
CARsgen Therapeutics Receives IND Clearance for BCMA-CAR-T Cells
CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therap...Read more
-
World | 19 June 2019 | News
Stoke Therapeutics announces pricing of IPO
Stoke Therapeutics, Inc., a biotechnology company that is pioneering a new way to treat the underlying cause o...Read more
-
Japan | 28 May 2019 | News
B dot Medical to develop ultra-compact proton cancer therapy
Japan based B dot Medical Inc. has announced that the company has initiated the development of an ultra-c...Read more
-
China | 28 May 2019 | News
Collaboration to establish comprehensive pharma, health system
Following 111, Inc.'s strategic partnership with Manulife-Sinochem last year, the Company has reached ano...Read more
ASIA-PACIFIC: MODEST RISE IN HEALTHCARE DEALS
Healthcare private equity tends to be less vulnerable to downturns than other sectors, so it expects demand for assets in Asia-Pacific to increase over the coming years. Buyout funds will invest more in growth-stage assets such as Chinese pharma. And as companies explore ways to increase access to healthcare, emerging trends, such as digital healthcare solutions, should gain steam in China, India and other countries. Investors will continue to seek deals in the provider and medtech sectors, and explore creative ways to deploy capital, such as public-toprivate takeovers. Baker McKenzie Global Transactions Forecast predicts a modest rise of 7 per cent in deals to $331 billion in 2019, as a number of cross-border and domestic megadeals are set to close.
